Stay up-to-date with the latest news and information from the life insurance industry by subscribing to Insights, our monthly newsletter.
Your Privacy Choices | Privacy Notices | Privacy Shield | Terms | Accessibility | Language Assistance / Non-Discrimination Notice | Asistencia de Idiomas / Aviso de no Discriminación | 語言協助 / 不䈚視通知
Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks — ® and ™ — are the property of their respective owners. © 2000-2024 Quest Diagnostics Incorporated. All rights reserved.
About 37 million people in the United States are currently affected by chronic kidney disease (CKD), and the prevalence of ensuing kidney failure is rising. ExamOne was asked how can insurers quickly and confidently determine if their applicant has kidney disease. In this case study we show how eGFR results highlighted in LabPiQture uncover or disprove chronic kidney disease.
Access case study here.